Dissolved
CVR: 21259519
Previous names: SAABYE & LERCHE A/S, S&L INVEST A/S
Not available
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 23 April 2008
CVR · view overview
3 employees
CVR · 1997
Director role ended: Christoph Nöll
CVR · 23/04/2008
View the full event history
NORDIC PHARMA INVEST A/S was a Danish company of the type Aktieselskab based in København SV, founded in 1959. The company has been dissolved on 23 April 2008. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named S&L INVEST A/S and SAABYE & LERCHE A/S. The company has 3 employees (1997).
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. NORDIC PHARMA INVEST A/S is registered in the Danish CVR register with the status Dissolved and ceased on 23 April 2008.
The CVR number of NORDIC PHARMA INVEST A/S is 21259519.
NORDIC PHARMA INVEST A/S had 3 employees in 1997 according to the Danish CVR register.
NORDIC PHARMA INVEST A/S was founded on 20 May 1959.
NORDIC PHARMA INVEST A/S was registered under the industry Ikke-finansielle holdingselskaber (industry code 642020).
NORDIC PHARMA INVEST A/S was located at c/o Nomeco A/S, Borgmester Christiansens Gade 40, 2450 København SV.
As of April 23, 2008, CJ Partnership I/S has stepped down as auditor of NORDIC PHARMA INVEST A/S.
As of April 23, 2008, Thomas Ehmann has left the board of directors of NORDIC PHARMA INVEST A/S.
As of April 23, 2008, Christoph Nöll has left the board of directors of NORDIC PHARMA INVEST A/S.
As of April 23, 2008, Christoph Nöll has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of April 23, 2008, Helmut Kraft has stepped down as chairman of NORDIC PHARMA INVEST A/S.
NORDIC PHARMA INVEST A/S was dissolved on April 23, 2008.
As of June 30, 2006, Helmut Kraft is registered as chairman of NORDIC PHARMA INVEST A/S.
As of June 30, 2006, Dirk Hennhöfer has stepped down as chairman of NORDIC PHARMA INVEST A/S.
As of December 3, 2004, Dirk Hennhöfer is registered as chairman of NORDIC PHARMA INVEST A/S.
As of December 3, 2004, Lorenz Näger has stepped down as chairman of NORDIC PHARMA INVEST A/S.
As of September 24, 2003, Christoph Nöll has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of September 24, 2003, Claudia Brandstetter has left the board of directors of NORDIC PHARMA INVEST A/S.
As of September 24, 2003, Christoph Nöll is registered as direktion of NORDIC PHARMA INVEST A/S.
As of September 24, 2003, Claudia Brandstetter has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of August 17, 2001, Claudia Brandstetter has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of August 17, 2001, Marko Thorsten Albert Grünewald has left the board of directors of NORDIC PHARMA INVEST A/S.
As of August 17, 2001, Claudia Brandstetter is registered as direktion of NORDIC PHARMA INVEST A/S.
As of August 17, 2001, Marko Thorsten Albert Grünewald has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Marko Thorsten Albert Grünewald has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Thomas Ehmann has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Kamma Schulz Beckmann has left the board of directors of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Jørgen Enegaard Nicolajsen has left the board of directors of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Lorenz Näger is registered as chairman of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Marko Thorsten Albert Grünewald is registered as direktion of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Jørgen Enegaard Nicolajsen has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of June 28, 2000, Erik Søndergaard has stepped down as chairman of NORDIC PHARMA INVEST A/S.
On June 28, 2000, the company changed its name from S&L INVEST A/S to NORDIC PHARMA INVEST A/S.
On November 15, 1999, the company changed its name from SAABYE & LERCHE A/S to S&L INVEST A/S.
As of August 22, 1997, Jørgen Enegaard Nicolajsen has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of August 22, 1997, Lars Lynggaard Poulsen has left the board of directors of NORDIC PHARMA INVEST A/S.
As of August 22, 1997, Jørgen Enegaard Nicolajsen is registered as direktion of NORDIC PHARMA INVEST A/S.
As of August 22, 1997, Kamma Schulz Beckmann has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of May 10, 1994, Kaj Schøning has left the board of directors of NORDIC PHARMA INVEST A/S.
As of May 10, 1994, Jens Thorsen has left the board of directors of NORDIC PHARMA INVEST A/S.
As of May 10, 1994, Erik Søndergaard has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of May 5, 1992, Arne Knud Rasmussen has left the board of directors of NORDIC PHARMA INVEST A/S.
As of March 26, 1992, Kaj Schøning has stepped down as direktion of NORDIC PHARMA INVEST A/S.
As of June 23, 1989, Henrik Thorsen has left the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, CJ Partnership I/S has been appointed auditor of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Kaj Schøning has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Kamma Schulz Beckmann has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Henrik Thorsen has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Jens Thorsen has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Arne Knud Rasmussen has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Lars Lynggaard Poulsen has joined the board of directors of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Kaj Schøning is registered as direktion of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Kamma Schulz Beckmann is registered as direktion of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Erik Søndergaard is registered as chairman of NORDIC PHARMA INVEST A/S.
As of May 20, 1959, Erik Søndergaard is registered as direktion of NORDIC PHARMA INVEST A/S.
NORDIC PHARMA INVEST A/S was founded on May 20, 1959.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
